{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T15:01:36Z","timestamp":1787238096996,"version":"build-2736575974"},"reference-count":93,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,7,28]],"date-time":"2020-07-28T00:00:00Z","timestamp":1595894400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81172444"],"award-info":[{"award-number":["81172444"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Therapy - Oncolytics"],"published-print":{"date-parts":[[2020,9]]},"DOI":"10.1016\/j.omto.2020.07.010","type":"journal-article","created":{"date-parts":[[2020,8,5]],"date-time":"2020-08-05T12:08:35Z","timestamp":1596629315000},"page":"409-418","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Endoscopic Molecular Imaging plus Photoimmunotherapy: A New Strategy for Monitoring and Treatment of Bladder Cancer"],"prefix":"10.1016","volume":"18","author":[{"given":"Yongjun","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chao","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaofeng","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.omto.2020.07.010_bib1","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1038\/nrclinonc.2016.212","article-title":"Beyond the margins: real-time detection of cancer using targeted fluorophores","volume":"14","author":"Zhang","year":"2017","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.omto.2020.07.010_bib2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.7150\/thno.37894","article-title":"18F-labeled, PSMA-targeted radiotracers: leveraging the advantages of radiofluorination for prostate cancer molecular imaging","volume":"10","author":"Werner","year":"2020","journal-title":"Theranostics"},{"key":"10.1016\/j.omto.2020.07.010_bib3","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.2967\/jnumed.118.220426","article-title":"Repurposing molecular imaging and sensing for cancer image-guided surgery","volume":"61","author":"Mondal","year":"2020","journal-title":"J.\u00a0Nucl. Med"},{"key":"10.1016\/j.omto.2020.07.010_bib4","doi-asserted-by":"crossref","first-page":"1887","DOI":"10.3390\/cancers11121887","article-title":"Photoimmunotherapy of ovarian cancer: a unique niche in the management of advanced disease","volume":"11","author":"Nath","year":"2019","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.omto.2020.07.010_bib5","doi-asserted-by":"crossref","first-page":"e69","DOI":"10.1002\/bjs.10789","article-title":"Modalities for image- and molecular-guided cancer surgery","volume":"105","author":"Stammes","year":"2018","journal-title":"Br. J. Surg."},{"key":"10.1016\/j.omto.2020.07.010_bib6","doi-asserted-by":"crossref","first-page":"2332","DOI":"10.1021\/acs.accounts.9b00273","article-title":"Near-infrared photoimmunotherapy of cancer","volume":"52","author":"Kobayashi","year":"2019","journal-title":"Acc. Chem. Res."},{"key":"10.1016\/j.omto.2020.07.010_bib7","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/j.eururo.2019.08.016","article-title":"European Association of Urology guidelines on non-muscle-invasive bladder cancer (TaT1 and carcinoma in\u00a0situ)\u20142019 update","volume":"76","author":"Babjuk","year":"2019","journal-title":"Eur. Urol."},{"key":"10.1016\/j.omto.2020.07.010_bib8","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1097\/MOU.0000000000000758","article-title":"Carcinoma in\u00a0situ of the bladder: why is it underdetected?","volume":"30","author":"Subiela","year":"2020","journal-title":"Curr. Opin. Urol."},{"key":"10.1016\/j.omto.2020.07.010_bib9","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1016\/j.euf.2019.03.012","article-title":"Carcinoma in\u00a0situ of the urinary bladder: a systematic review of current knowledge regarding detection, treatment, and outcomes","volume":"6","author":"Subiela","year":"2020","journal-title":"Eur. Urol. Focus"},{"key":"10.1016\/j.omto.2020.07.010_bib10","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1016\/j.euf.2016.12.011","article-title":"Role of restaging transurethral resection for T1 Non-muscle invasive bladder cancer: a systematic review and meta-analysis","volume":"4","author":"Naselli","year":"2018","journal-title":"Eur. Urol. Focus"},{"key":"10.1016\/j.omto.2020.07.010_bib11","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1016\/j.eururo.2018.02.014","article-title":"Repeat transurethral resection in non-muscle-invasive bladder cancer: a systematic review","volume":"73","author":"Cumberbatch","year":"2018","journal-title":"Eur. Urol."},{"key":"10.1016\/j.omto.2020.07.010_bib12","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/j.eururo.2005.12.031","article-title":"Predicting recurrence and progression in individual patients with stage Ta T1 bladder cancer using EORTC risk tables: a combined analysis of 2596 patients from seven EORTC trials","volume":"49","author":"Sylvester","year":"2006","journal-title":"Eur. Urol."},{"key":"10.1016\/j.omto.2020.07.010_bib13","doi-asserted-by":"crossref","first-page":"149","DOI":"10.3233\/BLC-170119","article-title":"Image-guided transurethral resection of bladder tumors\u2014current practice and future outlooks","volume":"3","author":"Chang","year":"2017","journal-title":"Bladder Cancer"},{"key":"10.1016\/j.omto.2020.07.010_bib14","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1007\/s00418-018-1738-x","article-title":"How cancer cells attach to urinary bladder epithelium in\u00a0vivo: study of the early stages of tumorigenesis in an orthotopic mouse bladder tumor model","volume":"151","author":"Erman","year":"2019","journal-title":"Histochem. Cell Biol."},{"key":"10.1016\/j.omto.2020.07.010_bib15","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1080\/14737140.2018.1451748","article-title":"Update on early instillation of chemotherapy after transurethral resection of non-muscle-invasive bladder cancer","volume":"18","author":"Oosterlinck","year":"2018","journal-title":"Expert Rev. Anticancer Ther."},{"key":"10.1016\/j.omto.2020.07.010_bib16","first-page":"902","article-title":"Multi-institution evaluation of sequential gemcitabine and docetaxel as rescue therapy for nonmuscle invasive bladder cancer","volume":"203","author":"Steinberg","year":"2020","journal-title":"J.\u00a0Urol."},{"key":"10.1016\/j.omto.2020.07.010_bib17","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1007\/s00345-018-2196-8","article-title":"Prospective randomized controlled trial of postoperative early intravesical chemotherapy with pirarubicin (THP) for solitary non-muscle invasive bladder cancer comparing single and two-time instillation","volume":"36","author":"Tanimoto","year":"2018","journal-title":"World J. Urol."},{"key":"10.1016\/j.omto.2020.07.010_bib18","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1038\/s41585-019-0220-4","article-title":"Optimizing pharmacokinetics of intravesical chemotherapy for bladder cancer","volume":"16","author":"Joice","year":"2019","journal-title":"Nat. Rev. Urol."},{"key":"10.1016\/j.omto.2020.07.010_bib19","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1111\/bju.13489","article-title":"Role of oral pentosan polysulphate in the reduction of local side effects of BCG therapy in patients with non-muscle-invasive bladder cancer: a pilot study","volume":"118","author":"Yadav","year":"2016","journal-title":"BJU Int."},{"key":"10.1016\/j.omto.2020.07.010_bib20","doi-asserted-by":"crossref","DOI":"10.1016\/j.eururo.2020.02.012","article-title":"Systematic review of the therapeutic efficacy of bladder-preserving treatments for non-muscle-invasive bladder cancer following intravesical bacillus Calmette- Gu\u00e9rin","author":"Li","year":"2020","journal-title":"Eur. Urol"},{"key":"10.1016\/j.omto.2020.07.010_bib21","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2147\/ITT.S202006","article-title":"Bacillus Calmette-Gu\u00e9rin (BCG) therapy for bladder cancer: an update","volume":"9","author":"Guallar-Garrido","year":"2020","journal-title":"ImmunoTargets Ther."},{"key":"10.1016\/j.omto.2020.07.010_bib22","doi-asserted-by":"crossref","first-page":"e354","DOI":"10.1016\/S1470-2045(19)30317-1","article-title":"Latest developments in molecular tracers for fluorescence image-guided cancer surgery","volume":"20","author":"Hernot","year":"2019","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.omto.2020.07.010_bib23","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1007\/s10549-018-4845-4","article-title":"Real-time, intraoperative detection of residual breast cancer in lumpectomy cavity walls using a novel cathepsin-activated fluorescent imaging system","volume":"171","author":"Smith","year":"2018","journal-title":"Breast Cancer Res. Treat."},{"key":"10.1016\/j.omto.2020.07.010_bib24","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1016\/j.jtho.2018.03.023","article-title":"Localization of pulmonary ground-glass opacities with folate receptor-targeted intraoperative molecular imaging","volume":"13","author":"Predina","year":"2018","journal-title":"J.\u00a0Thorac. Oncol."},{"key":"10.1016\/j.omto.2020.07.010_bib25","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/S2468-1253(17)30395-3","article-title":"Safety and effectiveness of SGM-101, a fluorescent antibody targeting carcinoembryonic antigen, for intraoperative detection of colorectal cancer: a dose-escalation pilot study","volume":"3","author":"Boogerd","year":"2018","journal-title":"Lancet Gastroenterol. Hepatol."},{"key":"10.1016\/j.omto.2020.07.010_bib26","doi-asserted-by":"crossref","first-page":"510","DOI":"10.3389\/fphar.2019.00510","article-title":"Emerging fluorescent molecular tracers to guide intra-operative surgical decision-making","volume":"10","author":"Debie","year":"2019","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.omto.2020.07.010_bib27","doi-asserted-by":"crossref","first-page":"260ra148","DOI":"10.1126\/scitranslmed.3009457","article-title":"Endoscopic molecular imaging of human bladder cancer using a CD47 antibody","volume":"6","author":"Pan","year":"2014","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.omto.2020.07.010_bib28","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1159\/000490875","article-title":"Identification of carbonic anhydrase IX as a novel target for endoscopic molecular imaging of human bladder cancer","volume":"47","author":"Wang","year":"2018","journal-title":"Cell. Physiol. Biochem."},{"key":"10.1016\/j.omto.2020.07.010_bib29","doi-asserted-by":"crossref","first-page":"2201","DOI":"10.1158\/1535-7163.MCT-16-0924","article-title":"Epidermal growth factor receptor (EGFR)-targeted photoimmunotherapy (PIT) for the treatment of EGFR-expressing bladder cancer","volume":"16","author":"Railkar","year":"2017","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.omto.2020.07.010_bib30","doi-asserted-by":"crossref","first-page":"2084","DOI":"10.1038\/s41598-019-38575-x","article-title":"Targeting epidermal growth factor receptor (EGFR) and human epidermal growth factor receptor 2 (HER2) expressing bladder cancer using combination photoimmunotherapy (PIT)","volume":"9","author":"Siddiqui","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.omto.2020.07.010_bib31","doi-asserted-by":"crossref","first-page":"19026","DOI":"10.18632\/oncotarget.24876","article-title":"Near infrared photoimmunotherapy targeting bladder cancer with a canine anti-epidermal growth factor receptor (EGFR) antibody","volume":"9","author":"Nagaya","year":"2018","journal-title":"Oncotarget"},{"issue":"2 Pt A","key":"10.1016\/j.omto.2020.07.010_bib32","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.molimm.2015.04.001","article-title":"In\u00a0vivo imaging with antibodies and engineered fragments","volume":"67","author":"Freise","year":"2015","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.omto.2020.07.010_bib33","doi-asserted-by":"crossref","first-page":"1880","DOI":"10.1245\/s10434-018-6453-2","article-title":"Intraoperative pancreatic cancer detection using tumor-specific multimodality molecular imaging","volume":"25","author":"Tummers","year":"2018","journal-title":"Ann. Surg. Oncol."},{"key":"10.1016\/j.omto.2020.07.010_bib34","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.3389\/fimmu.2017.01287","article-title":"Antibody or antibody fragments: implications for molecular imaging and targeted therapy of solid tumors","volume":"8","author":"Xenaki","year":"2017","journal-title":"Front. Immunol."},{"key":"10.1016\/j.omto.2020.07.010_bib35","doi-asserted-by":"crossref","first-page":"974","DOI":"10.7150\/thno.30835","article-title":"Near infrared imaging of epidermal growth factor receptor positive xenografts in mice with domain I\/II specific antibody fragments","volume":"9","author":"Bernhard","year":"2019","journal-title":"Theranostics"},{"key":"10.1016\/j.omto.2020.07.010_bib36","doi-asserted-by":"crossref","first-page":"9030","DOI":"10.1074\/jbc.RA118.002538","article-title":"Linker engineering in anti-TAG-72 antibody fragments optimizes biophysical properties, serum half-life, and high-specificity tumor imaging","volume":"293","author":"Long","year":"2018","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.omto.2020.07.010_bib37","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.2741\/4451","article-title":"Photo-thermal therapy of bladder cancer with anti-EGFR antibody conjugated gold nanoparticles","volume":"21","author":"Chen","year":"2016","journal-title":"Front. Biosci."},{"key":"10.1016\/j.omto.2020.07.010_bib38","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1158\/1541-7786.MCR-06-0069","article-title":"Targeting bladder tumor cells in\u00a0vivo and in the urine with a peptide identified by phage display","volume":"5","author":"Lee","year":"2007","journal-title":"Mol. Cancer Res."},{"key":"10.1016\/j.omto.2020.07.010_bib39","doi-asserted-by":"crossref","first-page":"79","DOI":"10.3892\/or.2016.4829","article-title":"A new non-muscle-invasive bladder tumor-homing peptide identified by phage display in\u00a0vivo","volume":"36","author":"Yang","year":"2016","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.omto.2020.07.010_bib40","doi-asserted-by":"crossref","first-page":"2100","DOI":"10.1158\/1535-7163.MCT-18-0212","article-title":"Phage display-derived peptide-based dual-modality imaging probe for bladder cancer diagnosis and resection postinstillation: a preclinical study","volume":"17","author":"Peng","year":"2018","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.omto.2020.07.010_bib41","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/j.urolonc.2010.06.011","article-title":"Identification of a bladder cancer-specific ligand using a combinatorial chemistry approach","volume":"30","author":"Zhang","year":"2012","journal-title":"Urol. Oncol."},{"key":"10.1016\/j.omto.2020.07.010_bib42","doi-asserted-by":"crossref","first-page":"11829","DOI":"10.1073\/pnas.1610472113","article-title":"Targeted imaging of urothelium carcinoma in human bladders by an ICG pHLIP peptide ex\u00a0vivo","volume":"113","author":"Golijanin","year":"2016","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.omto.2020.07.010_bib43","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1097\/MOU.0000000000000743","article-title":"Utilization of imaging for staging in bladder cancer: is there a role for MRI or PET-computed tomography?","volume":"30","author":"Cipollari","year":"2020","journal-title":"Curr. Opin. Urol."},{"key":"10.1016\/j.omto.2020.07.010_bib44","doi-asserted-by":"crossref","first-page":"329","DOI":"10.6004\/jnccn.2020.0011","article-title":"Bladder Cancer, Version 3.2020, NCCN Clinical Practice Guidelines in Oncology","volume":"18","author":"Flaig","year":"2020","journal-title":"J.\u00a0Natl. Compr. Canc. Netw."},{"key":"10.1016\/j.omto.2020.07.010_bib45","doi-asserted-by":"crossref","unstructured":"(2017). Bladder cancer: diagnosis and management of bladder cancer. BJU Int. 120, 755\u2013765.","DOI":"10.1111\/bju.14045"},{"key":"10.1016\/j.omto.2020.07.010_bib46","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1007\/s40336-018-0284-9","article-title":"A glance at imaging bladder cancer","volume":"6","author":"Salmanoglu","year":"2018","journal-title":"Clin. Transl. Imaging"},{"key":"10.1016\/j.omto.2020.07.010_bib47","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1007\/s11934-015-0496-8","article-title":"Preoperative imaging for staging bladder cancer","volume":"16","author":"McKibben","year":"2015","journal-title":"Curr. Urol. Rep."},{"key":"10.1016\/j.omto.2020.07.010_bib48","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1148\/radiol.2019182506","article-title":"Multiparametric MRI for bladder cancer: validation of VI-RADS for the detection of detrusor muscle invasion","volume":"291","author":"Wang","year":"2019","journal-title":"Radiology"},{"key":"10.1016\/j.omto.2020.07.010_bib49","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/j.euo.2020.02.007","article-title":"Diagnostic performance of vesical imaging reporting and data system for the prediction of muscle-invasive bladder cancer: a systematic review and meta-analysis","volume":"3","author":"Woo","year":"2020","journal-title":"Eur. Urol. Oncol"},{"key":"10.1016\/j.omto.2020.07.010_bib50","doi-asserted-by":"crossref","first-page":"981","DOI":"10.3389\/fonc.2019.00981","article-title":"Diagnostic accuracy of multi-parametric magnetic resonance imaging for tumor staging of bladder cancer: meta-analysis","volume":"9","author":"Zhang","year":"2019","journal-title":"Front. Oncol."},{"key":"10.1016\/j.omto.2020.07.010_bib51","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1007\/s00345-018-2439-8","article-title":"Comparative sensitivity and specificity of imaging modalities in staging bladder cancer prior to radical cystectomy: a systematic review and meta-analysis","volume":"37","author":"Crozier","year":"2019","journal-title":"World J. Urol."},{"key":"10.1016\/j.omto.2020.07.010_bib52","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1148\/radiol.2019190032","article-title":"Delayed 18F FDG PET\/CT imaging in the assessment of residual tumors after transurethral resection of bladder cancer","volume":"293","author":"Yan","year":"2019","journal-title":"Radiology"},{"key":"10.1016\/j.omto.2020.07.010_bib53","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1039\/C9BM01377F","article-title":"Targeted multifunctional nanomaterials with MRI, chemotherapy and photothermal therapy for the diagnosis and treatment of bladder cancer","volume":"8","author":"Tao","year":"2019","journal-title":"Biomater. Sci."},{"key":"10.1016\/j.omto.2020.07.010_bib54","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1007\/s00345-013-1197-x","article-title":"Perforation during TUR of bladder tumours influences the natural history of superficial bladder cancer","volume":"32","author":"Comploj","year":"2014","journal-title":"World J. Urol."},{"key":"10.1016\/j.omto.2020.07.010_bib55","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.eururo.2017.06.038","article-title":"Value of an immediate intravesical instillation of mitomycin C in patients with non-muscle-invasive bladder cancer: a prospective multicentre randomised study in 2243 patients","volume":"73","author":"Bosschieter","year":"2018","journal-title":"Eur. Urol."},{"key":"10.1016\/j.omto.2020.07.010_bib56","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.7150\/jca.34527","article-title":"Diagnostic accuracy of photodynamic diagnosis with 5-aminolevulinic acid, hexaminolevulinate and narrow band imaging for non-muscle invasive bladder cancer","volume":"11","author":"Chen","year":"2020","journal-title":"J.\u00a0Cancer"},{"key":"10.1016\/j.omto.2020.07.010_bib57","first-page":"361","article-title":"New optical imaging technologies for bladder cancer: considerations and perspectives","volume":"188","author":"Liu","year":"2012","journal-title":"J.\u00a0Urol."},{"key":"10.1016\/j.omto.2020.07.010_bib58","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.euf.2018.07.012","article-title":"Validation of confocal laser endomicroscopy features of bladder cancer: the next step towards real-time histologic grading","volume":"6","author":"Liem","year":"2020","journal-title":"Eur. Urol. Focus"},{"key":"10.1016\/j.omto.2020.07.010_bib59","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/j.pdpdt.2019.06.006","article-title":"Diagnostic accuracy of optical coherence tomography for bladder cancer: a systematic review and meta-analysis","volume":"27","author":"Xiong","year":"2019","journal-title":"Photodiagn. Photodyn. Ther."},{"key":"10.1016\/j.omto.2020.07.010_bib60","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1007\/978-3-319-93339-9_7","article-title":"Optical and cross-sectional imaging technologies for bladder cancer","volume":"175","author":"Kiss","year":"2018","journal-title":"Cancer Treat. Res."},{"key":"10.1016\/j.omto.2020.07.010_bib61","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1111\/imr.12527","article-title":"The CD47-SIRP\u03b1 signaling axis as an innate immune checkpoint in cancer","volume":"276","author":"Matlung","year":"2017","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.omto.2020.07.010_bib62","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1002\/cncr.24163","article-title":"Carbonic anhydrase IX in bladder cancer: a diagnostic, prognostic, and therapeutic molecular marker","volume":"115","author":"Klatte","year":"2009","journal-title":"Cancer"},{"key":"10.1016\/j.omto.2020.07.010_bib63","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.eururo.2018.09.036","article-title":"Devil in the detail: intratumour heterogeneity and personalised medicine for bladder cancer","volume":"75","author":"Griffin","year":"2019","journal-title":"Eur. Urol."},{"key":"10.1016\/j.omto.2020.07.010_bib64","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1038\/nrc.2017.77","article-title":"Tumour acidosis: from the passenger to the driver\u2019s seat","volume":"17","author":"Corbet","year":"2017","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.omto.2020.07.010_bib65","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.semcancer.2016.12.003","article-title":"Value of pH regulators in the diagnosis, prognosis and treatment of cancer","volume":"43","author":"Granja","year":"2017","journal-title":"Semin. Cancer Biol."},{"key":"10.1016\/j.omto.2020.07.010_bib66","doi-asserted-by":"crossref","first-page":"5834","DOI":"10.1073\/pnas.1303708110","article-title":"Family of pH (low) insertion peptides for tumor targeting","volume":"110","author":"Weerakkody","year":"2013","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.omto.2020.07.010_bib67","doi-asserted-by":"crossref","first-page":"E2811","DOI":"10.1073\/pnas.1715350115","article-title":"Peptides of pHLIP family for targeted intracellular and extracellular delivery of cargo molecules to tumors","volume":"115","author":"Wyatt","year":"2018","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.omto.2020.07.010_bib68","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.eururo.2019.09.035","article-title":"EAU-ESMO consensus statements on the management of advanced and variant bladder cancer\u2014an international collaborative multistakeholder effort: under the auspices of the EAU-ESMO guidelines committees","volume":"77","author":"Witjes","year":"2020","journal-title":"Eur. Urol."},{"key":"10.1016\/j.omto.2020.07.010_bib69","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1016\/j.eururo.2017.05.032","article-title":"Next-generation sequencing of nonmuscle invasive bladder cancer reveals potential biomarkers and rational therapeutic targets","volume":"72","author":"Pietzak","year":"2017","journal-title":"Eur. Urol."},{"key":"10.1016\/j.omto.2020.07.010_bib70","doi-asserted-by":"crossref","first-page":"e311","DOI":"10.1016\/j.clgc.2016.06.004","article-title":"A pilot study of vela laser for en bloc resection of papillary bladder cancer","volume":"15","author":"Zhang","year":"2017","journal-title":"Clin. Genitourin. Cancer"},{"key":"10.1016\/j.omto.2020.07.010_bib71","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1007\/s11255-018-1830-0","article-title":"Transurethral en bloc resection with bipolar button electrode for non-muscle invasive bladder cancer","volume":"50","author":"Zhang","year":"2018","journal-title":"Int. Urol. Nephrol."},{"key":"10.1016\/j.omto.2020.07.010_bib72","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1007\/s10103-018-2604-8","article-title":"A retrospective comparison of thulium laser en bloc resection of bladder tumor and plasmakinetic transurethral resection of bladder tumor in primary non-muscle invasive bladder cancer","volume":"34","author":"Li","year":"2019","journal-title":"Lasers Med. Sci."},{"key":"10.1016\/j.omto.2020.07.010_bib73","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/j.euf.2017.09.002","article-title":"Discrepancy between European Association of Urology guidelines and daily practice in the management of non-muscle-invasive bladder cancer: results of a European survey","volume":"5","author":"Hendricksen","year":"2019","journal-title":"Eur. Urol. Focus"},{"key":"10.1016\/j.omto.2020.07.010_bib74","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1016\/j.euf.2017.10.004","article-title":"Long-term outcomes from re-resection for high-risk non-muscle-invasive bladder cancer: a potential to rationalize use","volume":"5","author":"Gordon","year":"2019","journal-title":"Eur. Urol. Focus"},{"key":"10.1016\/j.omto.2020.07.010_bib75","doi-asserted-by":"crossref","first-page":"e028173","DOI":"10.1136\/bmjopen-2018-028173","article-title":"Diagnostic performance of image technique based transurethral resection for non-muscle invasive bladder cancer: systematic review and diagnostic meta-analysis","volume":"9","author":"Chen","year":"2019","journal-title":"BMJ Open"},{"key":"10.1016\/j.omto.2020.07.010_bib76","doi-asserted-by":"crossref","first-page":"338.e1","DOI":"10.1016\/j.urolonc.2018.03.015","article-title":"Monopolar vs. bipolar transurethral resection for non-muscle invasive bladder carcinoma: a post-hoc analysis from a randomized controlled trial","volume":"36","author":"Liem","year":"2018","journal-title":"Urol. Oncol."},{"key":"10.1016\/j.omto.2020.07.010_bib77","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1016\/j.eururo.2020.03.005","article-title":"Transurethral resection of bladder tumour: the neglected procedure in the technology race in bladder cancer","volume":"77","author":"Mostafid","year":"2020","journal-title":"Eur. Urol"},{"key":"10.1016\/j.omto.2020.07.010_bib78","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1097\/MOU.0000000000000377","article-title":"Transurethral en bloc resection of nonmuscle invasive bladder cancer: trend or hype","volume":"27","author":"Herrmann","year":"2017","journal-title":"Curr. Opin. Urol."},{"key":"10.1016\/j.omto.2020.07.010_bib79","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/j.euf.2016.12.004","article-title":"Current evidence of transurethral en-bloc resection of nonmuscle invasive bladder cancer","volume":"3","author":"Kramer","year":"2017","journal-title":"Eur. Urol. Focus"},{"key":"10.1016\/j.omto.2020.07.010_bib80","doi-asserted-by":"crossref","first-page":"2730","DOI":"10.1158\/1078-0432.CCR-16-0437","article-title":"Tumor-specific uptake of fluorescent bevacizumab-IRDye800CW microdosing in patients with primary breast cancer: a phase I feasibility study","volume":"23","author":"Lamberts","year":"2017","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.omto.2020.07.010_bib81","doi-asserted-by":"crossref","first-page":"3739","DOI":"10.1038\/s41467-018-05727-y","article-title":"Implementation and benchmarking of a novel analytical framework to clinically evaluate tumor-specific fluorescent tracers","volume":"9","author":"Koller","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.omto.2020.07.010_bib82","doi-asserted-by":"crossref","DOI":"10.1007\/s00345-020-03143-w","article-title":"Preliminary study on the application of en bloc resection combined with near-infrared molecular imaging technique in the diagnosis and treatment of bladder cancer","author":"Yang","year":"2020","journal-title":"World J. Urol."},{"key":"10.1016\/j.omto.2020.07.010_bib83","doi-asserted-by":"crossref","first-page":"2677","DOI":"10.1007\/s00345-019-02672-3","article-title":"En bloc resection improves the identification of muscularis mucosae in non-muscle invasive bladder cancer","volume":"37","author":"Liang","year":"2019","journal-title":"World J. Urol."},{"key":"10.1016\/j.omto.2020.07.010_bib84","first-page":"1192","article-title":"Efficacy and safety of photodynamic therapy for recurrent, high grade nonmuscle invasive bladder cancer refractory or intolerant to bacille Calmette-Gu\u00e9rin immunotherapy","volume":"190","author":"Lee","year":"2013","journal-title":"J.\u00a0Urol."},{"key":"10.1016\/j.omto.2020.07.010_bib85","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/j.euf.2018.08.005","article-title":"Photodynamic therapy in the treatment of bladder cancer: past challenges and current innovations","volume":"4","author":"Railkar","year":"2018","journal-title":"Eur. Urol. Focus"},{"key":"10.1016\/j.omto.2020.07.010_bib86","doi-asserted-by":"crossref","first-page":"3561","DOI":"10.1158\/1078-0432.CCR-18-3267","article-title":"CD47-targeted near-infrared photoimmunotherapy for human bladder cancer","volume":"25","author":"Kiss","year":"2019","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.omto.2020.07.010_bib87","doi-asserted-by":"crossref","first-page":"1814","DOI":"10.7150\/thno.38515","article-title":"Neutrophil infiltration and whole-cell vaccine elicited by N-dihydrogalactochitosan combined with NIR phototherapy to enhance antitumor immune response and T\u00a0cell immune memory","volume":"10","author":"Qi","year":"2020","journal-title":"Theranostics"},{"key":"10.1016\/j.omto.2020.07.010_bib88","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1186\/1476-4598-8-94","article-title":"Targeting EGFR with photodynamic therapy in combination with Erbitux enhances in\u00a0vivo bladder tumor response","volume":"8","author":"Bhuvaneswari","year":"2009","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.omto.2020.07.010_bib89","doi-asserted-by":"crossref","first-page":"80901","DOI":"10.1117\/1.JBO.21.8.080901","article-title":"Review of fluorescence guided surgery systems: identification of key performance capabilities beyond indocyanine green imaging","volume":"21","author":"DSouza","year":"2016","journal-title":"J.\u00a0Biomed. Opt."},{"key":"10.1016\/j.omto.2020.07.010_bib90","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.eururo.2007.01.064","article-title":"Photodynamic diagnostics and noninvasive bladder cancer: is it cost-effective in long-term application? A Germany-based cost analysis","volume":"52","author":"Burger","year":"2007","journal-title":"Eur. Urol."},{"key":"10.1016\/j.omto.2020.07.010_bib91","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1038\/nrurol.2014.245","article-title":"Hexaminolevulinate blue-light cystoscopy in non-muscle-invasive bladder cancer: review of the clinical evidence and consensus statement on appropriate use in the USA","volume":"11","author":"Daneshmand","year":"2014","journal-title":"Nat. Rev. Urol."},{"key":"10.1016\/j.omto.2020.07.010_bib92","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.pdpdt.2018.10.009","article-title":"Recent advances in optical imaging technologies for the detection of bladder cancer","volume":"24","author":"Raharja","year":"2018","journal-title":"Photodiagn. Photodyn. Ther."},{"key":"10.1016\/j.omto.2020.07.010_bib93","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1038\/s41566-018-0221-5","article-title":"Tackling standardization in fluorescence molecular imaging","volume":"12","author":"Koch","year":"2018","journal-title":"Nat. Photonics"}],"container-title":["Molecular Therapy - Oncolytics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2372770520301145?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2372770520301145?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,12,13]],"date-time":"2024-12-13T18:01:12Z","timestamp":1734112872000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2372770520301145"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9]]},"references-count":93,"alternative-id":["S2372770520301145"],"URL":"https:\/\/doi.org\/10.1016\/j.omto.2020.07.010","relation":{},"ISSN":["2372-7705"],"issn-type":[{"value":"2372-7705","type":"print"}],"subject":[],"published":{"date-parts":[[2020,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Endoscopic Molecular Imaging plus Photoimmunotherapy: A New Strategy for Monitoring and Treatment of Bladder Cancer","name":"articletitle","label":"Article Title"},{"value":"Molecular Therapy - Oncolytics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.omto.2020.07.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The Author(s).","name":"copyright","label":"Copyright"}]}}